Provided by Tiger Trade Technology Pte. Ltd.

VivoSim Lab, Inc.

0.2860
+0.00853.06%
Pre-market: 0.29380.0078+2.73%05:45 EDT
Volume:709.72K
Turnover:198.72K
Market Cap:4.25M
PE:-0.06
High:0.2898
Open:0.2775
Low:0.2714
Close:0.2775
52wk High:5.30
52wk Low:0.2625
Shares:14.85M
Float Shares:14.54M
Volume Ratio:0.49
T/O Rate:4.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4600
EPS(LYR):-1.6999
ROE:-343.10%
ROA:-89.50%
PB:-1.81
PE(LYR):-0.17

Loading ...

Company Profile

Company Name:
VivoSim Lab, Inc.
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
15
Office Location:
11555 Sorrento Valley Road,Suite 100,San Diego,California,United States
Zip Code:
92121
Fax:
- -
Introduction:
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Directors

Name
Position
Keith Murphy
Director and Executive Chairman of the Board
Douglas Jay Cohen
Lead Independent Director and Independent Director
Adam Stern
Director
Alison Tjosvold Milhous
Director
David Gobel
Director

Shareholders

Name
Position
Norman Staskey
Chief Financial Officer and President
Amar Sethi
Chief Scientific Officer
Keith Murphy
Director and Executive Chairman of the Board
Tony Lialin
Chief Commercial Officer